Imatron reports record EBCT sales revenue

Article

Rising sales of its proprietary electron-beam computed tomography scanner sent Imatron’s sales soaring during the second fiscal quarter of 2000. Revenue for the three months ending June 30 was $15.5 million, an increase of 87% over revenue of $8.3

Rising sales of its proprietary electron-beam computed tomography scanner sent Imatron’s sales soaring during the second fiscal quarter of 2000. Revenue for the three months ending June 30 was $15.5 million, an increase of 87% over revenue of $8.3 million for the same period a year earlier, the company announced.

Net income for the same three-month period increased $3 million to $1 million, compared to a net loss of $1.9 million for the same period a year ago. Second-quarter revenue increased 37% and net income increased 321% over Imatron’s first quarter, end March 31, 2000.

Imatron has shown rising sales of its scanners (which the company calls simply “EBT”) in the U.S. and abroad. The firm is investing in development of an international sales staff to increase business in Japan, China, Germany, and the Middle East (SCAN, 7/5/00).

The primary use of Imatron scanners has been to detect coronary artery calcium, a technique that has been called into question in a joint statement by the American College of Cardiology and the American Heart Association for the shortage of conclusive studies on its efficacy. Imatron’s defenders, in turn, criticized the consensus paper.

So far, the controversy has not dampened Imatron’s sales.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.